繁體中文Español
English
Facebook
Doxa ChemicalDoxa Chemical
  • About
  • Additives
    • Spredox™
      • Spredox Coating
      • Spredox Ink
      • Spredox Plastics
    • Doxflow™
    • Doxfoam™
    • Addox™
    • Doxmer™
    • Doxmed™
  • News
  • Reports
  • Contact

Test Report: Virucidal Efficacy of Doxmed V-1 on SARS-CoV-2(COVID-19)

January 5, 2021Product Profiles, Reportspeggy.chu
V-1

Study majorly based on the median tissue culture infectious dose (TCID50), immunofluorescent assay(IFA) and Cell counting Kit 8 to determinate the disinfection efficacy, Anti-virus efficacy and cell viability.

At 100, 200 and 400-fold dilution, Doxmed V-1 could inactive SARS-CoV-2 with a LRV(log reduction value) at 5, 3.66 and 2.66, respectively. The immunofluorescent assay also showed 200-fold and 400-fold dilution completely blocked SARS-CoV-2 infection. The best inhibition against SARS-CoV-2 was noted at 200~400- fold dilution in this cell-based study condition.

The full report is available for download below.

Please download the full report.

Download Report

Search

Categories

  • Events
  • News
  • Product Profiles
  • Reports
  • Uncategorized
© 2017 All rights reserved. Hou Chi Chemical Co. LTD